No Data
No Data
Zhejiang Gongdong Medical Technology (605369.SH): The controlling shareholder Shi Huiyong plans to reduce his holdings by no more than 2% through a bulk trade.
Zhejiang Gongdong Medical Technology (605369.SH) announced that the controlling shareholder Shi Huiyong planned to reduce the company's holdings by no more than 2,252,300 shares through block trading within 3 months after 15 trading days from the date of this announcement, and the total number of shares sold during any consecutive 90-day period shall not exceed 2% of the company's total share capital. The sale price will be determined based on the market price at the time of the sale.
Gongdong Medical (605369): The performance of high-score medical suppliers will return to rapid growth
Focusing on medical polymer consumables for nearly 40 years, it is an important link in the global industrial chain. Gongdong Medical was founded in 1985, focusing on R&D, production and sales of medical polymer consumables. Currently, experimental testing, vacuum blood collection systems, and body fluid collection have been formed
Gongdong Medical (605369): Short-term 2023 results are under pressure, and the pace of internationalization is accelerating
The full-year 2023 results were under short-term pressure, and gross margin declined somewhat. For the full year of 2023, the company achieved revenue of 975 million yuan (-33.61%), net profit attributable to mother of 109 million yuan (-66.53%), after deducting net income from mother
Express News | Antu Biotech and Gongdong Medical establish medical device companies
Gongdong Medical (605369.SH): The holding subsidiary was incorporated in Gongdong, Zhengzhou
Gelonghui, May 13丨Gongdong Medical (605369.SH) announced that recently, Gongdong, Zhengzhou has obtained a “Business License” issued by the Market Supervision Administration of the Zhengzhou Airport Economic Comprehensive Pilot Zone. The registered capital of Zhengzhou Gongdong is RMB 60 million, of which the company has pledged RMB 42 million, accounting for 70% of the registered capital; Antu Biotech has pledged a capital of RMB 18 million, accounting for 30% of the registered capital. An important customer of the shareholder Antu Biotech. Gongdong, Zhengzhou, which was invested and established by the company this time will focus on R&D, production of medical polymer consumables and related products and services
Gongdong Medical (605369.SH) announced first-quarter results, net profit of 45.109 million yuan, an increase of 56.02% over the previous year
Zhitong Finance App News, Gongdong Healthcare (605369.SH) released its report for the first quarter of 2024. The company's revenue was 272 million yuan, up 20.22% year on year; net profit attributable to shareholders of listed companies was 45.109 million yuan, up 56.02% year on year; net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss was 43.445 million yuan, up 85.73% year on year; basic earnings per share were 0.40 yuan/share.
No Data